2023 Women’s Health M&A Overview

Amboy Street Ventures announces its latest investment in Evvy, a company committed to restoring equity in healthcare by leveraging overlooked female biomarkers, starting with the vaginal microbiome.

This week, Ute M. Arndt, reveals what CPG conglomerates find valuable when considering an acquisition of a start-up.

This week, Leslie Schrock, breaks down the future of fertility – what trends to look for and which markets to bet on.

Amboy Street invests in HerMD which offers menopause and sexual health care through a hybrid delivery model with in-person and virtual services.

This week Bayer Exec, Laura Clark-Kelly, speaks to the complex nature of obtaining insurance coverage for women’s health and sexual wellness companies.

Amboy Street Ventures is excited to announce its latest investment in Evvy, the at-home vaginal microbiome testing and care company, leveraging female-specific biomarkers to radically reinvent how we understand and treat the female body.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space. This week we take a look at private equity funds buying women’s health and sexual wellness companies.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space. This week we take a look at established healthcare giants acquiring women’s health and sexual health innovation.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space. This week we take a look at late stage venture-backed companies growing through M&A.